Patients taking semaglutide, the primary component of Ozempic and Wegovy, have a decreased likelihood of experiencing kidney failure, requiring a transplant, or dying as suggested by recent research.
Hot-TopicsPatients taking semaglutide, the primary component of Ozempic and Wegovy, have a decreased likelihood of experiencing kidney failure, requiring a transplant, or dying as suggested by recent research.
Hot-Topics